In order to elucidate the molecular mechanism of action of ZR2002 in the tumor, we analyzed the effects of its two main components, i.e., the 2-chloroethyl DNA-damaging moiety with P-H2AX and the quinazoline-based scaffold as an EGFR inhibitor. The gene discussed is H2AX; the disease is neoplasm.